NanoPowers (Switzerland) a development-stage medical device company focused on urinary incontinence, closed a $4.5M Series A financing. Participants include Novartis Venture Funds, Initiative Capital Romandie and Gran Plasa.
Neotract (Pleasanton, CA) a clinical-stage medical device company focused on urological disorders, closed a $23.7M Series B financing. Participants include Johnson & Johnson Development Corp. and New Enterprise Associates.
NeoTract, Inc. (Pleasanton, CA) medical device company focused on urological and gynecological disorders, closed a $7.4M Series A financing. Participants include New Enterprise Associates.